Cargando…
Lipid nanomaterials-based RNA therapy and cancer treatment
We summarize the most important advances in RNA delivery and nanomedicine. We describe lipid nanoparticle-based RNA therapeutics and the impacts on the development of novel drugs. The fundamental properties of the key RNA members are described. We introduced recent advances in the nanoparticles to d...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031258/ https://www.ncbi.nlm.nih.gov/pubmed/36970213 http://dx.doi.org/10.1016/j.apsb.2022.10.004 |
_version_ | 1784910566912950272 |
---|---|
author | Zhang, Xingcai Hai, Luo Gao, Yibo Yu, Guocan Sun, Yingli |
author_facet | Zhang, Xingcai Hai, Luo Gao, Yibo Yu, Guocan Sun, Yingli |
author_sort | Zhang, Xingcai |
collection | PubMed |
description | We summarize the most important advances in RNA delivery and nanomedicine. We describe lipid nanoparticle-based RNA therapeutics and the impacts on the development of novel drugs. The fundamental properties of the key RNA members are described. We introduced recent advances in the nanoparticles to deliver RNA to defined targets, with a focus on lipid nanoparticles (LNPs). We review recent advances in biomedical therapy based on RNA drug delivery and state-of-the-art RNA application platforms, including the treatment of different types of cancer. This review presents an overview of current LNPs based RNA therapies in cancer treatment and provides deep insight into the development of future nanomedicines sophisticatedly combining the unparalleled functions of RNA therapeutics and nanotechnology. |
format | Online Article Text |
id | pubmed-10031258 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-100312582023-03-23 Lipid nanomaterials-based RNA therapy and cancer treatment Zhang, Xingcai Hai, Luo Gao, Yibo Yu, Guocan Sun, Yingli Acta Pharm Sin B Review We summarize the most important advances in RNA delivery and nanomedicine. We describe lipid nanoparticle-based RNA therapeutics and the impacts on the development of novel drugs. The fundamental properties of the key RNA members are described. We introduced recent advances in the nanoparticles to deliver RNA to defined targets, with a focus on lipid nanoparticles (LNPs). We review recent advances in biomedical therapy based on RNA drug delivery and state-of-the-art RNA application platforms, including the treatment of different types of cancer. This review presents an overview of current LNPs based RNA therapies in cancer treatment and provides deep insight into the development of future nanomedicines sophisticatedly combining the unparalleled functions of RNA therapeutics and nanotechnology. Elsevier 2023-03 2022-10-11 /pmc/articles/PMC10031258/ /pubmed/36970213 http://dx.doi.org/10.1016/j.apsb.2022.10.004 Text en © 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Zhang, Xingcai Hai, Luo Gao, Yibo Yu, Guocan Sun, Yingli Lipid nanomaterials-based RNA therapy and cancer treatment |
title | Lipid nanomaterials-based RNA therapy and cancer treatment |
title_full | Lipid nanomaterials-based RNA therapy and cancer treatment |
title_fullStr | Lipid nanomaterials-based RNA therapy and cancer treatment |
title_full_unstemmed | Lipid nanomaterials-based RNA therapy and cancer treatment |
title_short | Lipid nanomaterials-based RNA therapy and cancer treatment |
title_sort | lipid nanomaterials-based rna therapy and cancer treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031258/ https://www.ncbi.nlm.nih.gov/pubmed/36970213 http://dx.doi.org/10.1016/j.apsb.2022.10.004 |
work_keys_str_mv | AT zhangxingcai lipidnanomaterialsbasedrnatherapyandcancertreatment AT hailuo lipidnanomaterialsbasedrnatherapyandcancertreatment AT gaoyibo lipidnanomaterialsbasedrnatherapyandcancertreatment AT yuguocan lipidnanomaterialsbasedrnatherapyandcancertreatment AT sunyingli lipidnanomaterialsbasedrnatherapyandcancertreatment |